Nutraveris

Category 'NEWS'

Thursday, July 18, 2019
Category : NEWS, INGREDIENTS, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags:

Our Artificial Intelligence solutions, developed by our experts, NOL Datasolution to Create & NOL Compliance to Launch your products, inform you :  

 

Since several years, many health benefits have been conferred to avocado. Recently, two new studies have provided new evidences of such benefits, with improvements in cognition function and modulation of gut microflora following consumption of fresh avocado.

Avocado: a fruit with various health benefits

In a randomized and controlled trial, Edwards et al. (2019) have shown that one avocado per day for 12 weeks was able to improve selective attention and serum lutein concentrations in adults with overweight or obesity (n = 72). No change in macular pigment optical density has been measured in this study.

The same research team has also examined the effects of fresh avocado (1 per day for 12 weeks on gut microflora still in overweight or obese subjects (n = 160) (Thompson et al., 2019). The avocado intake was associated with increased acetate and total short-chain fatty acid concentrations, and with increased relative abundance of Faecalibacterium.

 

Therefore, avocado consumption may have beneficial effects on gastrointestinal health and cognitive function, confirming the interest of this fruit.

 

Edwards C, Walk A, Thompson S, Reeser G, Erdman J Jr, Burd N, Holscher H, Kha N. Effects of a 12-week Avocado Randomized-controlled Trial on Cognitive Function and Lutein Status Among Adults with Overweight and Obesity (OR05-01-19). Curr Dev Nutr. 2019 Jun 13;3(Suppl 1). pii: nzz029.OR05-01-19.

Thompson S, Edwards C, Reeser G, Khan N, Holscher H. Effects of Avocado Consumption on Gastrointestinal Microbial Metabolite Concentrations and Taxa Abundances: A Randomized, Controlled Trial (OR23-07-19). Curr Dev Nutr. 2019 Jun 13;3(Suppl 1). pii: nzz040.OR23-07-19.

 

NUTRAVERIS is the Leading European consultancy on Regulatory & Scientific affairs in Nutrition and Health, founded 13 years ago, to help you formulate, ensure the compliance and substantiation of your products in the 28 EU Member States. 

Thanks to our strong know-how and experience of regulatory compliance, notifications, novel foods, health claims, medical writing,…We, as experts, created Artificial Intelligence solutions, that we use in our everyday missions:
-NOL Datasolution to CREATE new products thanks to Regulatory, Scientific & Marketing data.
-NOL Compliance to LAUNCH products into the different EU member states thanks to automated Compliance analysis, Labeling generation and Monitoring & updating at anytime.

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Tuesday, July 16, 2019
Category : NEWS, INGREDIENTS, REGULATORY | Author : experts | Comment : No Comments
Tags:

Our Artificial Intelligence solutions, developed by our experts, NOL Datasolution to Create & NOL Compliance to Launch your products, inform you :  

 

In Italy, the Istituto Superiore di Sanità reported 21 cases of acute, non-infectious and non-contagious cholestatic hepatitis following the consumption of products containing turmeric. The Italian Authorities are carrying out checks to identify the cause of these cases of hepatitis. Pending the analysis, consumers are requested, as a precaution, to suspend the consumption of numerous products.

 

Alerts on food supplements containing turmeric

The Belgian Authorities have also issued a warning about a company which decided to withdraw a product containing turmeric and black pepper from sale.

The French Authorities are awaiting the return of the investigations of the Italian Authorities.

To date the exact cause of the adverse effects is not yet clearly established.

 

NUTRAVERIS is the Leading European consultancy on Regulatory & Scientific affairs in Nutrition and Health, founded 13 years ago, to help you formulate, ensure the compliance and substantiation of your products in the 28 EU Member States. 

Thanks to our strong know-how and experience of regulatory compliance, notifications, novel foods, health claims, medical writing,…We, as experts, created Artificial Intelligence solutions, that we use in our everyday missions:
-NOL Datasolution to CREATE new products thanks to Regulatory, Scientific & Marketing data.
-NOL Compliance to LAUNCH products into the different EU member states thanks to automated Compliance analysis, Labeling generation and Monitoring & updating at anytime.

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Thursday, July 11, 2019
Category : NEWS, INGREDIENTS, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags:

Our Artificial Intelligence solutions, developed by our experts, NOL Datasolution to Create & NOL Compliance to Launch your products, inform you :  

 

The aim of this randomized, double-blinded and placebo-controlled study was to examine the effects of green cardamom (3 g/day for 3 months) in overweight or obese patients with non-alcoholic fatty liver disease (NAFLD). The authors assessed the effects of cardamom on glucose metabolism, insulin sensitivity, blood lipids, and irisin levels.

Green cardamom improves metabolism of obese subjects with non-alcoholic fatty liver disease.

Compared to placebo, the cardamom supplementation increased irisin, HDL-cholesterol and insulin sensitivity. It also reduced fasting blood insulin, triglycerides, LDL-cholesterol, and the grade of fatty liver (p < 0.05). No change in fasting blood glucose, total cholesterol and BMI have been noted.

 

These results suggest therefore that green cardamom can be beneficial for overweight or obese subjects with NAFLD.

 

Daneshi-Maskooni M, Keshavarz SA, Qorbani M, Mansouri S, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind, randomized placebo-controlled clinical trial. BMC Complement Altern Med. 2019 Mar 12;19(1):59.

 

NUTRAVERIS is the Leading European consultancy on Regulatory & Scientific affairs in Nutrition and Health, founded 13 years ago, to help you formulate, ensure the compliance and substantiation of your products in the 28 EU Member States. 

Thanks to our strong know-how and experience of regulatory compliance, notifications, novel foods, health claims, medical writing,…We, as experts, created Artificial Intelligence solutions, that we use in our everyday missions:
-NOL Datasolution to CREATE new products thanks to Regulatory, Scientific & Marketing data.
-NOL Compliance to LAUNCH products into the different EU member states thanks to automated Compliance analysis, Labeling generation and Monitoring & updating at anytime.

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Tuesday, July 9, 2019
Category : NEWS, REGULATORY | Author : experts | Comment : No Comments
Tags:

Our Artificial Intelligence solutions, developed by our experts, NOL Datasolution to Create & NOL Compliance to Launch your products, inform you :  

 

Following the approval by the European Parliament on 17 April 2019, the Council has formally adopted on 13 June 2019 a new Regulation on the transparency and sustainability of the EU risk assessment in the food chain. This new Regulation mainly amends the General Food Law Regulation (178/2002). It aims at increasing the transparency of the EU risk assessment in the food chain, on strengthening the reliability, objectivity and independence of the studies used by European Food Safety Authority (EFSA), and revisiting the governance of EFSA.

 

The Regulation stipulates that all studies and information supporting a request for a scientific output by EFSA are to be made public. This will be done at the very early stage of the risk assessment process, in an easily accessible electronic format with the possibility to search, download and print the studies. Confidential information will be protected in duly justified circumstances. Confidentiality claims will be assessed by EFSA.

Other measures which will also ensure a more robust, independent and transparent risk assessment process are particularly:

  • A notification obligation for applicants and laboratories when studies are commissioned and creation of a database of commissioned studies: This will provide a mechanism by which EFSA will be able to double-check whether all studies commissioned by an applicant in the context of its application for an authorisation, have been submitted;
  • Consultation of stakeholders and of the general public on submitted studies to ensure EFSA’s comprehensive access to existing evidence underpinning its risk assessment;
  • Pre-submission advice on the applicable rules and the required content of an application dossier, to be provided by EFSA upon request to potential applicants;
  • Fact-finding missions by the Commission to ensure the compliance of laboratories/studies with standards;
  • Possibility for the Commission to ask EFSA to commission studies in exceptional circumstances to verify evidence used in its risk assessment process.

 

The new Regulation is expected to be published in the Official Journal in September 2019 and will become applicable 18 months later.

 

NUTRAVERIS is the Leading European consultancy on Regulatory & Scientific affairs in Nutrition and Health, founded 13 years ago, to help you formulate, ensure the compliance and substantiation of your products in the 28 EU Member States. 

Thanks to our strong know-how and experience of regulatory compliance, notifications, novel foods, health claims, medical writing,…We, as experts, created Artificial Intelligence solutions, that we use in our everyday missions:
-NOL Datasolution to CREATE new products thanks to Regulatory, Scientific & Marketing data.
-NOL Compliance to LAUNCH products into the different EU member states thanks to automated Compliance analysis, Labeling generation and Monitoring & updating at anytime.

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

 

Thursday, July 4, 2019
Category : NEWS, INGREDIENTS, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags:

Our Artificial Intelligence solutions, developed by our experts, NOL Datasolution to Create & NOL Compliance to Launch your products, inform you :  

 

This randomized and placebo-controlled study examined the effects of Phyllanthus amarus for the management of hangover symptoms. 15 subjects have been enrolled and received for 10 days a placebo or 750 mg/day of PHYLLPRO®, A P. amarus leaf extract, before alcohol intoxication.

Efficacy of Phyllanthus amarus for reducing hangover symptoms.

The supplementation accelerated alcohol removal from blood in comparison to placebo at 12-hour post-intoxication (p < 0.0001). The Hangover Severity Score showed lower hangover symptoms in the active group, whereas nausea, headache, anorexia, tremulousness, diarrhea and dizziness were noted in the placebo group (p < 0.05). Higher fatigue and tension were also noted in the placebo group. The assessment of cytokines showed an anti-inflammatory effect of P. amarus.

 

Therfeore, this small pilot study suggests that a P. amarus leaf extract can reduce hangover symptoms, partly by preventing alcohol-induced inflamamation.

 

 

George A, Udani JK, Yusof A. Effects of Phyllanthus amarus PHYLLPROTM leaves on hangover symptoms: a randomized, double-blinded, placebo-controlled crossover study. Pharm Biol. 2019 Dec; 57(1):145-153.

 

NUTRAVERIS is the Leading European consultancy on Regulatory & Scientific affairs in Nutrition and Health, founded 13 years ago, to help you formulate, ensure the compliance and substantiation of your products in the 28 EU Member States. 

Thanks to our strong know-how and experience of regulatory compliance, notifications, novel foods, health claims, medical writing,…We, as experts, created Artificial Intelligence solutions, that we use in our everyday missions:
-NOL Datasolution to CREATE new products thanks to Regulatory, Scientific & Marketing data.
-NOL Compliance to LAUNCH products into the different EU member states thanks to automated Compliance analysis, Labeling generation and Monitoring & updating at anytime.

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87